| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199901145 | 1999-08-20 | ||
| PCT/DK2000/000459WO2001013901A2 (en) | 1999-08-20 | 2000-08-18 | A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| Publication Number | Publication Date |
|---|---|
| PL356667A1true PL356667A1 (en) | 2004-06-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL00356667APL356667A1 (en) | 1999-08-20 | 2000-08-18 | A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| Country | Link |
|---|---|
| EP (1) | EP1210079A2 (en) |
| JP (1) | JP2003507419A (en) |
| AR (1) | AR025343A1 (en) |
| AU (1) | AU6558900A (en) |
| NZ (1) | NZ517833A (en) |
| PL (1) | PL356667A1 (en) |
| RU (1) | RU2309733C2 (en) |
| WO (1) | WO2001013901A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000078296A2 (en)* | 1999-06-17 | 2000-12-28 | Basf Aktiengesellschaft | Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders |
| CA2480227A1 (en)* | 2002-03-28 | 2003-10-09 | Oxis International, Inc. | Neuroprotectant methods, compositions, and screening methods thereof |
| ATE534384T1 (en)* | 2003-01-17 | 2011-12-15 | Vital Health Sciences Pty Ltd | COMPOUNDS WITH ANTI-PROLIFERATION PROPERTIES |
| JP2008509877A (en)* | 2003-09-05 | 2008-04-03 | ラート・マティアス | Pharmaceutical formulation for suppressing cardiovascular disease, usually containing vitamin C, magnesium, green tea extract |
| US9168216B2 (en) | 2005-06-17 | 2015-10-27 | Vital Health Sciences Pty. Ltd. | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| ES2999020T3 (en) | 2010-02-05 | 2025-02-24 | Phosphagenics Ltd | Carrier comprising non-neutralised tocopheryl phosphate |
| KR20130010473A (en) | 2010-03-30 | 2013-01-28 | 포스파제닉스 리미티드 | Transdermal delivery patch |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| CA3007587C (en) | 2015-12-09 | 2023-12-05 | Phosphagenics Limited | Pharmaceutical formulation |
| ES2983921T3 (en) | 2016-12-21 | 2024-10-28 | Avecho Biotechnology Ltd | Process for phosphorylating a complex alcohol |
| WO2022059776A1 (en)* | 2020-09-17 | 2022-03-24 | 昭和電工株式会社 | Autophagy activator |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4122157A (en)* | 1977-03-04 | 1978-10-24 | Richardson-Merrell Inc. | Nitrofurantoin sustained release tablet |
| US4369172A (en)* | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| ATE41740T1 (en)* | 1984-08-30 | 1989-04-15 | Rodisma Pharma Prod Gmbh | PROCEDURES FOR RETARDATION OF VITAMINS C AND E. |
| RU2063750C1 (en)* | 1993-07-21 | 1996-07-20 | Сергеев Александр Васильевич | Composition showing adaptogenic action |
| JPH07227256A (en)* | 1993-12-24 | 1995-08-29 | Takeda Chem Ind Ltd | Liquid agent for oral administration |
| IL109539A0 (en)* | 1994-05-03 | 1994-08-26 | Yissum Res Dev Co | Substained-release pharmaceutical system for the delivery of antioxidants |
| US5560928A (en)* | 1995-06-23 | 1996-10-01 | Defelice; Stephen L. | Nutritional and/or dietary composition and method of using the same |
| US5773031A (en)* | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
| IT1283478B1 (en)* | 1996-07-22 | 1998-04-21 | Roberto Valducci | COMPOSITIONS FOR NUTRITIONAL SUPPLEMENT INCLUDING WATER-SOLUBLE EXTENDED-RELEASE VITAMINS |
| FR2772615B1 (en)* | 1997-12-23 | 2002-06-14 | Lipha | MULTILAYER TABLET FOR INSTANT RELEASE THEN PROLONGED ACTIVE SUBSTANCES |
| Publication number | Publication date |
|---|---|
| JP2003507419A (en) | 2003-02-25 |
| AU6558900A (en) | 2001-03-19 |
| RU2309733C2 (en) | 2007-11-10 |
| NZ517833A (en) | 2004-01-30 |
| WO2001013901A3 (en) | 2001-09-07 |
| RU2002107015A (en) | 2003-11-10 |
| EP1210079A2 (en) | 2002-06-05 |
| WO2001013901A2 (en) | 2001-03-01 |
| AR025343A1 (en) | 2002-11-20 |
| Publication | Publication Date | Title |
|---|---|---|
| GB2338414B (en) | Intravesical drug delivery system | |
| AU6158001A (en) | Drug/drug delivery systems for the prevention and treatment of vascular disease | |
| AU5343899A (en) | Catheter drug delivery system and method for use | |
| EP1100508B8 (en) | Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone and brotizolam for treating or preventing sleep disorders | |
| AU2879100A (en) | Formulation and system for intra-oral delivery of pharmaceutical agents | |
| IL127189A0 (en) | Compositions methods and devices for the transdermal delivery of drugs | |
| EP1231864A4 (en) | Drug delivery catheters that attach to tissue and methods for their use | |
| ZA9810641B (en) | Pharmaceutical hydrogel formulations and associated drug delivery devices and methods | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| GB9904629D0 (en) | Oral drug delivery system | |
| GB9701904D0 (en) | A system for the delivery of drugs and therapeutic agents | |
| EP1036573A4 (en) | Device for delivering drug through skin or mucosa | |
| AU2938100A (en) | Transdermal drug delivery system and method | |
| MXPA02000598A (en) | Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective composition of same. | |
| IL127572A (en) | Pharmaceutical composition and medicament for nasal administration | |
| EP1087753A4 (en) | Targeted liposomal drug delivery system | |
| LT96148A (en) | Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction | |
| PL356667A1 (en) | A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress | |
| IL211081A0 (en) | Methods and devices for providing prolonged drug therapy | |
| HUP0200468A3 (en) | Resorcinol derivatives and pharmaceutical compositions containing them | |
| HUP0401913A3 (en) | Medicine for preventing and treating bromhidrosis | |
| HUP0203908A3 (en) | Osmotic delivery system and method for delivery first of all of medicine | |
| EP1173192A4 (en) | Methods and compositions for targeted drug delivery | |
| IL126671A0 (en) | Drug preferably for inhibiting inflammation | |
| HUP0200812A3 (en) | Vitamin d analogues and their pharmaceutical use |
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |